Thiol Reactive Nitroimidazoles: Radiosensitization Studies in Vitro and in Vivo

Summary

Using Chinese hamster V79 cells in vitro a study has been made of the radiosensitizing properties of 4– or 5–nitroimidazoles substituted in the 2, 5 or 4 position with various halo, sulphur ether, sulphonamide, sulphonate, ether or nitro groups. Values of E¹₇ (the one-electron reduction potential measured versus the normal hydrogen electrode at pH7) vary in the range −178 to −565 mV. All the compounds, with one exception, are more efficient radiosensitizers than would be predicted from their redox potentials, and the factor, Ĉ_1·6/C_1·6, by which a compound is more efficient has been calculated. The second-order rate constants, k₂, for reaction of these nitroimidazoles with glutathione and/or dithiothreitol were determined. Within each class of nitroimidazole there is a trend for k₂ to increase with increasing redox potential. However, there is no clear trend between k₂ and Ĉ_1·6/C_1·6. The concentration required to cause a 50 per cent depletion of intracellular glutathione was determined for selected compounds, as was the ability of glutathione-S-transferase to catalyse reaction with thiols. These observations suggested that the relative thiol reactivity measured under chemically controlled conditions does not necessarily indicate thiol reactivity intracellularly. Studies using the MT tumour in mice showed that the high levels of radiosensitization seen in vitro could not be duplicated in vivo. This was attributed to thiol reactivity, resulting in low metabolic stability and rapid depletion of sensitizer in vivo.

• radiosensitization
• nitroimidazol-thiol reactivity
• reduction potential